NOT FOR REPRINT
Page Printed from: benefitspro.com/2025/01/28/house-bill-would-eliminate-warning-labels-for-critical-illness-insurance-products/
The new bill would undo a Biden-era move and return the rules to what they were in Trump’s first term.

House Republicans have started the legislative work needed to eliminate a federal warning label for fixed-indemnity health insurance products such as critical illness insurance, cancer insurance and hospital indemnity insurance.
Rep. Buddy Carter, R-Ga., has joined with six Republicans to introduce the Healthcare Freedom and Choice Act bill.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Allison Bell, a senior reporter at ThinkAdvisor and BenefitsPRO, previously was an associate editor at National Underwriter Life & Health. She has a bachelor’s degree in economics from Washington University in St. Louis and a master’s degree in journalism from the Medill School of Journalism at Northwestern University. She can be reached through X at @Think_Allison.
More from this author ⟶
By ALM Staff | January 28, 2025
Nominate yourself, a peer, or a colleague for BenefitsPRO’s 2025 Advisor of the Year Award before the extended deadline on Wednesday, January 29th!
By Allison Bell | January 28, 2025
Rep. Jeff Van Drew has revived a bill he offered in the previous Congress.
By Allison Bell | January 28, 2025
Members of the health benefits policy-shaping committees in Congress are talking about encouraging bipartisanship.
White Paper
Sponsored by Noom Health
Breaking the GLP-1 Cost Cycle: Transforming Access, Cutting Costs, and Shaping the Future of Obesity Care
As obesity rates rise, GLP-1 medications are gaining popularity. Yet, the multifactorial obesity epidemic presents challenges for your clients as more of their employees demand GLP-1’s. This white paper explores strategies to help clients cut costs, improve employee health outcomes, and achieve a measurable ROI.
Browse More Resources ›
Report
Sponsored by New Benefits
Benefit Innovation Report: Revolutionizing Employee Support With Innovative Non-Insured Benefits To Drive Growth for Both Employers and Employees
This report reveals the top non-insured benefits that not only reduce costs but also address the rising challenges of burnout, financial stress, and work-life balance. Give your clients the edge they need to support their employees while driving business growth. Download the report now to learn more!
Browse More Resources ›
White Paper
Sponsored by Noom Health
Breaking the GLP-1 Cost Cycle: Transforming Access, Cutting Costs, and Shaping the Future of Obesity Care
As obesity rates rise, GLP-1 medications are gaining popularity. Yet, the multifactorial obesity epidemic presents challenges for organizations as more employees seek GLP-1’s. This white paper explores actionable strategies to help cut costs, improve employee health outcomes, and achieve a measurable ROI.
Browse More Resources ›
Already have an account? Sign In Now
Follow Us On
Copyright © 2025 ALM Global, LLC. All Rights Reserved.